Public trial registry of the CCC-Munich

Trial ACCEPT

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ACCEPT
World
Full title
:

Gemcitabine in combination with the oral irreversible ErbB Inhibitot Afatinib versus Gemcitabine alone in patients with metastatic pancreatic cancer: an explorative randomized phase II trial

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C25.0 Pankreas Karzinom
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Hana Algül Keine Organisationseinheit angegeben Magnifier